The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem […]

The post FDA needs to act boldly on unproven exosome therapies appeared first on The Niche.